Tracon Pharmaceuticals Inc Expected To Post A Loss Of 8 Cents A Share: Earnings Preview

TRACON Pharmaceuticals

01/03/2024 21:39

* TRACON Pharmaceuticals Inc  TCON.OQ   TCON.O  is expected
to show a rise in quarterly revenue when it reports  results on
March 5 for the period ending December 31 2023
    * The San Diego California-based  company is expected to
report
revenue of $1 million, according to the mean estimate from 3
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for TRACON Pharmaceuticals
Inc is
for a loss of 8 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $4.00​, above​ its last closing price
of $0.18. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.10       -0.06      0.29      Beat    546.2
 Jun. 30 2023  -0.28       -0.10      0.22      Beat    320
 Mar. 31 2023  -0.27       -0.26      -0.36     Missed  -38.5​
 Dec. 31 2022  -0.27       -0.27      -0.31     Missed  -14.8
 ​​Sep.        -0.28       -0.28      -0.30     Missed  -6.2
 30 2022                                                
 Jun. 30 2022  -0.36       -0.37      -0.31     Beat    16.8​
 Mar. 31 2022  -0.42       -0.42      -0.48     Missed  -15
 Dec. 31 2021  -0.36       -0.35      -0.40     Missed  -13.4
 This summary was machine generated March 1 at 21:39 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)